The Board of Directors has adopted, subject to shareholder approval, an amendment to Article IV of the Articles of Incorporation to increase authorized capital by increasing the number of authorized shares of Common Stock from 200,000,000 to 300,000,000 shares. The Company’s authorized capital stock is 207 million shares, consisting of 200 million shares of Common Stock, (“Common Stock”), and 7 million shares of 8% cumulative convertible preferred stock, par value $3.00 (“Preferred Stock”). As of the Record Date 153,219,484 shares of Common Stock and 1,700 shares of Preferred Stock were issued and outstanding, respectively. An indeterminate number of shares of Common Stock may be acquired upon conversion of the Company’s Convertible Debentures and Series A Convertible Preferred Stock, since there is no minimum conversion price, and options to acquire 6,821,933 shares with exercise prices ranging from $0.43 to $2.00 per share, and 13,830,926 warrants with exercise prices ranging from $0.13 to $3.00 per share are outstanding, respectively. The additional 100 million shares of Common Stock to be authorized would provide the Board with flexibility for future financial and capital requirements, for acquisitions, to facilitate efforts to obtain a strategic partner and financing for projects in Kazakhstan and other desirable locations, and to facilitate the growth and expansion of the company. The additional shares also would be available for stock options and other employee benefit plans, for stock splits and dividends, and for issuance upon conversion of its outstanding convertible debt and equity securities. The Company does not currently have any plans, agreements or commitments or understandings for the issuance of additional shares of Common Stock, except upon exercise of outstanding warrants and options, pursuant to employee benefit plans, or upon conversion of outstanding debt securities. Depending of the circumstances, issuance of additional shares of common Stock could affect the existing holders of shares by diluting the voting power of the outstanding shares. The shareholders do not have preemptive rights under the Articles of Incorporation and will not have such rights with respect to the additional authorized shares of Common Stock. If this proposal is not approved, the Company’s ability to adequately finance, develop and exploit its projects, both overseas and in the United States, would be severely jeopardized. Furthermore, the Company may be required to redeem all or a substantial portion of the 5% Convertible Debenture and Series A Convertible Preferred Stock in cash if it is unable to obtain approval of this proposal, which would materially impair the company’s liquidity and financial condition. Although the Company’s Board of Directors does not consider the proposed amendment to the Company’s Articles of Incorporation to be an antitakeover proposal, the ability to issue additional Common Stock could also be used to discourage hostile takeover attempts of the company. Among other things, the additional shares could be privately placed thereby diluting the stock ownership of persons seeking to obtain control of the company, or the Board could adopt a stockholders’ rights plan that would provide for the issuance of additional shares of Common Stock in the event of certain purchases not approved by the Board of Directors. Although the Board of Directors has no current plans to propose measures to the Company’s stockholders that may have the effect of discouraging takeovers, such measures may be proposed if warranted from time to time in the judgment of the Board of Directors. In addition, the Board of Directors may, from time to time, adopt other measures or enter into agreements that could have the effect of discouraging takeovers, but that do not require stockholder approval. 15 |